Description
Angilex (hexetidine) Oral Spray 30 ml
Composition
Active ingredient: Hexetidine
Other ingredients: Purified water, ethanol, glycerol, saccharin sodium, peppermint oil.
Mechanism of Action
Hexetidine exhibits antimicrobial properties by effectively reducing the levels of various bacteria and fungi in the oral cavity, making it a valuable agent in the treatment of oral infections.
Pharmacological Properties
Angilex oral spray containing hexetidine acts as an antimicrobial and anti-inflammatory agent, targeting oral infections and reducing associated symptoms.
Indications for Use
Angilex oral spray is indicated for the treatment of mouth and throat infections, including sore throat, mouth ulcers, and gingivitis.
Contraindications
Do not use Angilex oral spray if you are allergic to any of the ingredients. Consult a healthcare professional before use if pregnant or breastfeeding.
Side Effects
Common side effects may include mild irritation or allergic reactions. Discontinue use and consult a healthcare provider if any adverse reactions occur.
Usage Instructions
Adults and children over 6 years: Spray 3-5 times into the mouth 2-3 times daily after meals. Shake the bottle before use and spray directly into the mouth, targeting the affected area. Do not swallow immediately after spraying.
Benefits Compared to Analogues
Angilex oral spray offers a targeted approach to treating oral infections with its dual action of antimicrobial and anti-inflammatory effects, providing comprehensive care for oral health issues.
Suitable Patient Groups
Angilex oral spray is suitable for adults and children over 6 years of age. Elderly patients and individuals seeking targeted oral infection treatment can also benefit from its use.
Storage and Shelf Life
Store Angilex oral spray in a cool, dry place away from direct sunlight. Check the expiry date on the packaging and do not use the product if expired.
Packaging Description
Angilex oral spray is available in a 30 ml bottle with a convenient spray mechanism for easy application.
